NEW YORK (GenomeWeb) – Provista Diagnostics today announced it has expanded a licensing deal for certain biomarkers and autoantibody technologies identified by researchers at the Biodesign Institute of Arizona State University.
Registering provides access to this and other free content.
Already have an account?Login Now.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.